Search

Sales: sales@allfluoro.com

Phone: 0086-400-0216110

Phone: 0086-15958047586(wechat，whatsApp)

中文
Search

News Center

Bio Health World online-Global online cloud show opens today
2020-10-21
Due to 2019-nCoV, South Korea plans to invest $980 million in high-profile medical devices by 2025.
NASH candidate drug obtained FDA fast track certification
2020-09-24
Terns pharmaceuticals (China) announced on 16th that it’s candidate drug for NASH indication, TERN-201 (SSAO inhibitor), has obtained the fast track certification of the US...
Inflazome received 380million from Roche for NLRP3 inhibitor
2020-09-24
On September 21, 2020, Inflazome announced that it had reached a share purchase agreement with Roche. They received an advance payment of 380million euros and were eligible to achieve ....
Analysis on the current situation and future development prospect of China's CDMO Market
2020-06-18
CMO (contract manufacturing organization), i.e. contract manufacturing organization / contract customization production, originated in the late 1980s. As the global economy retreated at that time....
Improvement of the structure of fluorinated drugs
2020-05-18
The introduction of fluorine atoms or fluorine-containing groups into drug molecules can change the permeability and metabolic stability of drug molecules, regulate their PKA and liposolubility..
1 2 3 4 5 6
Request a sample
Request a quote

You want to know more? Send the product list to your inbox.

Product List
Mobile website

Copyright @ 2020 Allfluoro pharmaceutical co. ltd.(Shanghai)17033936